|
 |
|
 |
 |
Amirul Feisal bin Wan Zahir
Age : 41 years
Qualification
| · |
Bachelor of Science Economics (Accounting and Finance), London School of Economics, University of London |
| · |
Associate Member, Institute of Chartered Accountants England and Wales |
Position on the Board
| · |
Non-Independent Non-Executive Director |
Date Appointed to the Board
Working Experience and Occupation
| · |
Prior to En. Amirul Feisal's secondment to CCM as Executive Director, he was the Executive Vice President for Special Projects in Permodalan Nasional Berhad. En. Amirul Feisal started his career in KPMG Plc. in the Audit Division based in London and left as an Assistant Manager to Schroders Investment Banking in Kuala Lumpur in 1997. He remained at Schroders (later acquired by Salomon Smith Barney and subsequently renamed Citigroup Global Markets) until 2004. During that period, he worked in various departments within the Investment Banking Division including the Project Finance and Privatisation Department, Corporate Finance Group, Mergers & Acquisition Group and the Industrial/Large Cap Group based in Kuala Lumpur, Singapore and Hong Kong. In 2004, En. Amirul Feisal joined BinaFikir Sdn. Bhd., a Malaysian-based boutique advisory firm as a shareholder and Executive Director. He was also the Managing Director, Investment Banking for Maybank Investment Bank from 2008
until September 2010. |
Membership of Board Committees
Directorships of Other Public Companies
| · |
Chemical Company of Malaysia Berhad |
|
|
|
| |
|
| |
Important legal information - please read
the Privacy Policy & Disclaimer before
proceeding.
Copyright © 2012 CCM Duopharma Biotech Bhd. All Rights
Reserved. |
|
|
|